Riskpilot← Back to searchSign inGet full accessLäkare Linnéa Binfaré AB
ABActiveOrg 5569724544Frodevägen 22Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 1K
-92% vs 2023
EBITDA margin
-8000.0%
-281% vs 2023
Equity ratio
96.6%
Financial strength
Net profit 2024
SEK -65K
-2067% vs 2023
| Revenue | SEK 1K | -92% |
| EBITDA | SEK -80K | -281% |
| Net profit | SEK -65K | -2067% |
| Total assets | SEK 206K | -29% |
| Equity | SEK 199K | -25% |
| Employees | 0 | — |
Legal name
Läkare Linnéa Binfaré AB
Org number
5569724544
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 maj 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Binfaré, Karin Linnéa Wiklund, Bo Lennart
Company purpose
Bolaget ska bedriva verksamhet som legitimerad läkare samt specialistläkare inom gynekologi och obstetrik, som huvudman samt konsult. Utbildning inom hälsa och sjukvård, försäljning av medicinska produkter. Bedriva handel med värdepapper och fast och lös egendom. Företaget kan också bedriva verksamhet inom fritidsnäring.
Address
Frodevägen 22
Email
linnea.binfare@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 56 | 92 | 10 | 12 | 1 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 11 | 71 | −20 | −21 | −80 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 11 | 71 | −20 | −21 | −80 |
| Net financials | — | — | — | — | — |
| Profit before tax | 10 | 71 | 8 | −3 | −65 |
| Tax | −3 | −15 | −2 | −0 | −0 |
| Net profit | 7 | 56 | 6 | −3 | −65 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 295 | 335 | 312 | 291 | 206 |
| Equity | 204 | 260 | 266 | 264 | 199 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 30 | 14 | 13 | 13 | 8 |
| Total debt | 30 | 14 | 13 | 13 | 8 |
EBITDA margin
-8000.0%
This company
15.8%
Market median
-50733% vs market
20202024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
-32.7%
This company
18.4%
Market median
-278% vs market
20202024
Net profit margin
-6500.0%
This company
8.1%
Market median
-80347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkare Linnéa Binfaré AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Linnéa Binfaré | Chief Executive Officer | 0 companies |
| Marco Binfaré | Deputy Board Member | 0 companies |
| Eva Elisabeth Wiklund | Board of Directors | 0 companies |
| Bo Lennart Wiklund | Deputy Board Member | 0 companies |